PART I Overview CV Sciences, Inc. (CV Sciences, the Company, we, our or us) is a consumer wellness company specializing in nutraceuticals and plant-based foods. Our hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Our +PlusCBD branded products are sold at select retail locations throughout the U.S. and are the top-selling brands of hemp extracts in the natural...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126598 | EDGAR | 38K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-046180 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0000950170-24-038736 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001510964-23-000016 | EDGAR | — |
| 2022-04-04 | 2021-12-31 | 0001510964-22-000033 | EDGAR | — |
| 2021-03-19 | 2020-12-31 | 0001510964-21-000012 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001510964-20-000026 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001510964-19-000007 | EDGAR | — |
| 2018-03-30 | 2017-12-31 | 0001683168-18-000816 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001683168-17-000725 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280515 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0000950170-25-108171 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071559 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127040 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096390 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-059926 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001510964-23-000039 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001510964-23-000032 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001510964-23-000024 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001510964-22-000088 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001510964-22-000069 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001510964-22-000043 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001193125-26-126211 | EDGAR | 5K words |
| 2026-03-10 | 0001193125-26-100436 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280116 | EDGAR | — |
| 2025-10-10 | 0001193125-25-237188 | EDGAR | — |
| 2025-09-18 | 0001193125-25-207436 | EDGAR | — |
| 2025-08-13 | 0000950170-25-107984 | EDGAR | — |
| 2025-06-05 | 0000950170-25-081934 | EDGAR | — |
| 2025-05-14 | 0000950170-25-071347 | EDGAR | — |
| 2025-03-27 | 0000950170-25-045761 | EDGAR | — |
| 2025-02-20 | 0000950170-25-023618 | EDGAR | — |
247 total filings indexed. 215 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001510964 |
| Ticker | CVSI |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report